3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
CNS
1
Conditions
Lymphoma, Follicular
3
Brain Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Gliosarcoma
2
Glioblastoma
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma, Kaposi
1
Sarcoma
1
Renal Insufficiency
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Interventions
Temozolomide
30
Radiotherapy
23
Filgrastim
12
Carmustine
12
Irinotecan
11
Carboplatin
11
Chemotherapy, Adjuvant
9
O(6)-benzylguanine
8
Etoposide
7
Surgical Procedures, Operative
6
Magnetic Resonance Spectroscopy
6
Vincristine
5
Peripheral Blood Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
5
Cyclophosphamide
5
sargramostim
4
motexafin gadolinium
4
Topotecan
4
Thiotepa
4
Paclitaxel
4
Melphalan
4
Gene Expression Profiling
4
Gemcitabine
4
Drug Therapy
4
Busulfan
4
temsirolimus
3
etoposide phosphate
3
Specimen Handling
3
Mass Spectrometry
3
Imatinib Mesylate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Central Nervous System Neoplasms
×
Cilengitide
×
Clear all
NCT00884598
2024-05-10
CIRAB
Universitätsmedizin Mannheim
Phase 1
Completed
19 enrolled